Molecular basis for ligand modulation of the cannabinoid CB1 receptor

Karthik Ramesh, Daniel M. Rosenbaum

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


The cannabinoid CB1 receptor is the most abundant G protein coupled receptor (GPCR) in the central nervous system, which mediates the functional response to endocannabinoids and Cannabis compounds. A variety of ligands for CB1 receptors have been developed as promising drug candidates for the treatment of neurological disorders. New high-resolution structures of CB1 receptor in different functional states have significantly improved our molecular understanding of CB1 ligand interactions, selectivity, receptor activation and allosteric modulation. These advances have paved the way for development of novel ligands for different therapeutic applications. In this review, we describe the structural determinants for modulation of CB1 receptors by different types of ligands, as well as the differences between CB1 and its homologous, the CB2 receptor. LINKED ARTICLES: This article is part of a themed issue on Structure Guided Pharmacology of Membrane Proteins (BJP 75th Anniversary). To view the other articles in this section visit

Original languageEnglish (US)
Pages (from-to)3487-3495
Number of pages9
JournalBritish Journal of Pharmacology
Issue number14
StatePublished - Jul 2022

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Molecular basis for ligand modulation of the cannabinoid CB1 receptor'. Together they form a unique fingerprint.

Cite this